Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025;9(3):257-260.

PACE A and PACE B trial - What a radiation oncologist needs to know

Shounak J Kamat  1 , Trinanjan Basu  1 , Jay P Sahu  1 , Rohith R Menon  1 , Ajinkya Gadekar  1 , Ghazala K Roshan  1 , Durva A Kurkure  1 , Rohit Kabre  1 , Riddhijyoti Talukdar  1
Affiliations
  • PMID: 40476281
  • PMCID: PMC12136680 (available on )

PACE A and PACE B trial - What a radiation oncologist needs to know

Shounak J Kamat et al. J Radiosurg SBRT. 2025.
No abstract available

Keywords: SBRT; fractionation; outcome; prostate cancer.

PubMed Disclaimer

References

    1. Hamdy FC, Donovan JL, Lane JA, Metcalfe C, Davis M, Turner EL, Martin RM, Young GJ, Walsh EI, Bryant RJ, Bollina P, Doble A, Doherty A, Gillatt D, Gnanapragasam V, Hughes O, Kockelbergh R, Kynaston H, Paul A, Paez E, Powell P, Rosario DJ, Rowe E, Mason M, Catto JWF, Peters TJ, Oxley J, Williams NJ, Staffurth J, Neal DE, ProtecT Study Group Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer N Engl J Med 2023; 388: 1547–1558 10.1056/NEJMoa2214122 - DOI - PubMed
    1. Dearnaley DP, Hall E, Lawrence D, Huddart RA, Eeles R, Nutting CM, Gadd J, Warrington A, Bidmead M, Horwich A. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects Br J Cancer 2005; 92 (3): 488–498 - PMC - PubMed
    1. Dearnaley DP, Sydes MR, Langley RE, Graham JD, Huddart RA, Syndikus I, Matthews JH, Scrase CD, Jose CC, Logue J, Stephens RJ, RT01 Collaborators The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: results from the MRC RT01 trial (ISRCTN47772397) Radiother Oncol 2007; 83 (1): 31–41 - PubMed
    1. Pollack A, Zagars GK, Starkschall G, Antolak JA, Lee JJ, Huang E, von Eschenbach AC, Kuban DA, Rosen I. Prostate cancer radiation dose response: results of the MD Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 2002; 53 (5): 1097–1105 - PubMed
    1. Matzinger O, Duclos F, van den Bergh A, Carrie C, Villà S, Kitsios P, Poortmans P, Sundar S, van der Steen-Banasik EM, Gulyban A, Collette L, Bolla M, EORTC Radiation Oncology Group Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991 Eur J Cancer 2009; 45 (16): 2825–2834 - PubMed